Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.315, 2001-01, pp. : 10-11
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Cost effectiveness of pacemakers less shocking than ICDs
Inpharma, Vol. 1, Iss. 1522, 2006-01 ,pp. :
Access to resources
Recommend
ICDs: better QOL than amiodarone in ventricular arrhythmias
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 381, 2002-01 ,pp. :
Vinorelbine + doxorubicin vs doxorubicin: QOL no different in breast cancer
Inpharma, Vol. 1, Iss. 1250, 2000-01 ,pp. :
Amiodarone worth it for cardiomyopathy vs ICDs in the US?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 421, 2003-01 ,pp. :
Amiodarone worth it for cardiomyopathy vs ICDs in the US?
Inpharma, Vol. 1, Iss. 1396, 2003-01 ,pp. :